These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26341711)
1. Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models. Petrucci S; Ginevrino M; Valente EM Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S16-20. PubMed ID: 26341711 [TBL] [Abstract][Full Text] [Related]
2. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein. Rutherford NJ; Moore BD; Golde TE; Giasson BI J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882 [TBL] [Abstract][Full Text] [Related]
3. The many faces of alpha-synuclein mutations. Kasten M; Klein C Mov Disord; 2013 Jun; 28(6):697-701. PubMed ID: 23674458 [TBL] [Abstract][Full Text] [Related]
4. Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein. Guan Y; Zhao X; Liu F; Yan S; Wang Y; Du C; Cui X; Li R; Zhang CX Front Cell Neurosci; 2020; 14():159. PubMed ID: 32595456 [TBL] [Abstract][Full Text] [Related]
5. Link between the SNCA gene and parkinsonism. Xu W; Tan L; Yu JT Neurobiol Aging; 2015 Mar; 36(3):1505-18. PubMed ID: 25554495 [TBL] [Abstract][Full Text] [Related]
6. A53T in a parkinsonian family: a clinical update of the SNCA phenotypes. Tambasco N; Nigro P; Romoli M; Prontera P; Simoni S; Calabresi P J Neural Transm (Vienna); 2016 Nov; 123(11):1301-1307. PubMed ID: 27250986 [TBL] [Abstract][Full Text] [Related]
7. The different faces of the p. A53T alpha-synuclein mutation: A screening of Greek patients with parkinsonism and/or dementia. Breza M; Koutsis G; Karadima G; Potagas C; Kartanou C; Papageorgiou SG; Paraskevas GP; Kapaki E; Stefanis L; Panas M Neurosci Lett; 2018 Apr; 672():136-139. PubMed ID: 29233723 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice. Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344 [TBL] [Abstract][Full Text] [Related]
13. Parkinson disease: α-synuclein mutational screening and new clinical insight into the p.E46K mutation. Pimentel MM; Rodrigues FC; Leite MA; Campos Júnior M; Rosso AL; Nicaretta DH; Pereira JS; Silva DJ; Della Coletta MV; Vasconcellos LF; Abreu GM; Dos Santos JM; Santos-Rebouças CB Parkinsonism Relat Disord; 2015 Jun; 21(6):586-9. PubMed ID: 25817515 [TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease. Hope AD; Myhre R; Kachergus J; Lincoln S; Bisceglio G; Hulihan M; Farrer MJ Neurosci Lett; 2004 Aug; 367(1):97-100. PubMed ID: 15308306 [TBL] [Abstract][Full Text] [Related]
16. Parkinsonism due to A53E α-synuclein gene mutation: Clinical, genetic, epigenetic, and biochemical features. Picillo M; Lizarraga KJ; Friesen EL; Chau H; Zhang M; Sato C; Rooke G; Munhoz RP; Rogaeva E; Fraser PE; Kalia SK; Kalia LV Mov Disord; 2018 Dec; 33(12):1950-1955. PubMed ID: 30423204 [TBL] [Abstract][Full Text] [Related]
17. Change in the Oligomeric State of α-Synuclein Variants in Living Cells. Fan HF; Chen WL; Chen YZ; Huang JW; Shen YX ACS Chem Neurosci; 2022 Apr; 13(8):1143-1164. PubMed ID: 35394271 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Fuchs J; Nilsson C; Kachergus J; Munz M; Larsson EM; Schüle B; Langston JW; Middleton FA; Ross OA; Hulihan M; Gasser T; Farrer MJ Neurology; 2007 Mar; 68(12):916-22. PubMed ID: 17251522 [TBL] [Abstract][Full Text] [Related]
20. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity. Sanjeev A; Mattaparthi VSK J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]